Understanding the mechanism of ionic gelation for synthesis of chitosan nanoparticles using qualitative techniques

被引:65
作者
Kunjachan, Sijumon [1 ,2 ]
Jose, Sajan [1 ]
Lammers, Twan [2 ]
机构
[1] Mahatma Gandhi Univ, Dept Pharmaceut Sci, Kottayam, Kerala, India
[2] Rhein Westfal TH Aachen, Univ Clin, Dept Expt Mol Imaging EXMI, Aachen, Germany
关键词
Chitosan; cross linking; ionic gelation; microparticles; nanoparticles;
D O I
10.4103/0973-8398.68467
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We focused on qualitatively exploring the basic mechanisms involved in the Ionic gelation (IG) process, a method quite frequently used for synthesis of chitosan (CS) microparticles (MPs) and nanoparticles (NPs). We synthesized CS MPs and NPs using the Ionic gelation and microemulsion methods, and characterized the CS NPs and MPs at different stages of formulation using scanning electron microscopy (SEM) and fluorescence microscopy. Fourier Transform Infrared (FTIR) analysis was carried out to confirm effective cross-linking. Moreover, for the first time, we reported the mechanisms of IG technique for CS NP and MP synthesis with qualitative proof: (1) Complex formation of long chain oligomers with polyanions (long beaded structures) (2) cleavages at weak sites on addition of acid (HCl) (3) formation of CS NPs on chain scission. The versatility of IG for the synthesis of CS MPs and NPs was proved and compared with the microemulsion technique, thereby enhancing the wide spectrum of its use in therapeutics and biomedical applications.
引用
收藏
页码:148 / 153
页数:6
相关论文
共 18 条
[11]   Chitins and Chitosans as Immunoadjuvants and Non-Allergenic Drug Carriers [J].
Muzzarelli, Riccardo A. A. .
MARINE DRUGS, 2010, 8 (02) :292-312
[12]   IN-VITRO ASSESSMENT OF BIOADHESION FOR PERIODONTAL AND BUCCAL DRUG-DELIVERY [J].
NEEDLEMAN, IG ;
SMALES, FC .
BIOMATERIALS, 1995, 16 (08) :617-624
[13]  
ONSOYEN E, 1990, J CHEM TECHNOL BIOT, V49, P395
[14]  
Patel Vishnu M., 2007, Acta Pharmaceutica (Zagreb), V57, P61, DOI 10.2478/v10007-007-0005-9
[15]   Chitosans as absorption enhancers for poorly absorbable drugs .2. Mechanism of absorption enhancement [J].
Schipper, NGM ;
Olsson, S ;
Hoogstraate, JA ;
deBoer, AG ;
Varum, KM ;
Artursson, P .
PHARMACEUTICAL RESEARCH, 1997, 14 (07) :923-929
[16]   Chitosan: some pharmaceutical and biological aspects - an update [J].
Singla, AK ;
Chawla, M .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2001, 53 (08) :1047-1067
[17]   Optimization of the formulation design of chitosan microspheres containing cisplatin [J].
Wang, YM ;
Sato, H ;
Adachi, I ;
Horikoshi, I .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1996, 85 (11) :1204-1210
[18]   A Novel Methotrexate Delivery System Based on Chitosan-Methotrexate Covalently Conjugated Nanoparticles [J].
Wu, Ping ;
He, Xiaoxiao ;
Wang, Kemin ;
Tan, Weihong ;
He, Chunmei ;
Deng, Mingbin .
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2009, 5 (05) :557-564